|
US4489056A
(en)
*
|
1982-06-30 |
1984-12-18 |
Merck & Co., Inc. |
Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance
|
|
US4513143A
(en)
*
|
1982-12-01 |
1985-04-23 |
Sri International |
Preparation of ketene acetals
|
|
US4532335A
(en)
*
|
1983-03-07 |
1985-07-30 |
Sri International |
Preparation of ketene acetals by rearrangement of allyl and substituted allyl acetals
|
|
US4639366A
(en)
*
|
1984-06-06 |
1987-01-27 |
Merck & Co., Inc. |
Polymers containing pendant acid functionalities and labile backbone bonds
|
|
US4549010A
(en)
*
|
1984-06-27 |
1985-10-22 |
Merck & Co., Inc. |
Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal
|
|
US4754745A
(en)
*
|
1984-11-21 |
1988-07-05 |
Horowitz Bruce S |
Conformable sheet material for use in brachytherapy
|
|
US4697575A
(en)
*
|
1984-11-21 |
1987-10-06 |
Henry Ford Hospital |
Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
|
|
US4780319A
(en)
*
|
1985-07-08 |
1988-10-25 |
Merck & Co., Inc. |
Organic acids as catalysts for the erosion of polymers
|
|
US4764364A
(en)
*
|
1986-02-25 |
1988-08-16 |
S R I International |
Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
|
|
US4855132A
(en)
*
|
1986-02-25 |
1989-08-08 |
S R I International |
Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
|
|
US4763642A
(en)
*
|
1986-04-07 |
1988-08-16 |
Horowitz Bruce S |
Intracavitational brachytherapy
|
|
ATE97929T1
(de)
*
|
1986-05-15 |
1993-12-15 |
Hoechst Ag |
Biologisch abbaubare polymere fuer depotzubereitungen mit kontrollierter wirkstoffabgabe.
|
|
US4713441A
(en)
*
|
1986-08-01 |
1987-12-15 |
Sandoz Pharmaceuticals Corp. |
Polyacetal hydrogels formed from divinyl ethers and polyols
|
|
US4842868A
(en)
*
|
1986-09-26 |
1989-06-27 |
Helwing Robert F |
Covalently bonded active agents with carbonium ion base groups
|
|
DE3700128A1
(de)
*
|
1987-01-03 |
1988-07-14 |
Hoechst Ag |
Biologisch abbaubare poly- (hydroxyalkyl)- aminodicarbonsaeure-derivate, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe
|
|
US4913903A
(en)
*
|
1987-02-04 |
1990-04-03 |
Alza Corporation |
Post-surgical applications for bioerodible polymers
|
|
US4957986A
(en)
*
|
1988-08-02 |
1990-09-18 |
E. I. Du Pont De Nemours And Company |
Partially fluorinated polyesters from ketene acetals and fluorine monomers
|
|
US4906714A
(en)
*
|
1988-08-02 |
1990-03-06 |
E. I. Du Pont De Nemours And Company |
Partially fluorinated polyesters from ketene acetals and fluorinated vinyl monomers
|
|
US4957998A
(en)
*
|
1988-08-22 |
1990-09-18 |
Pharmaceutical Delivery Systems, Inc. |
Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho ester linkages
|
|
US5108755A
(en)
*
|
1989-04-27 |
1992-04-28 |
Sri International |
Biodegradable composites for internal medical use
|
|
US4946931A
(en)
*
|
1989-06-14 |
1990-08-07 |
Pharmaceutical Delivery Systems, Inc. |
Polymers containing carboxy-ortho ester and ortho ester linkages
|
|
US5013821A
(en)
*
|
1989-06-15 |
1991-05-07 |
Pharmaceutical Delivery Systems, Inc. |
Ortho and thio-ortho ester polymer
|
|
EP0489843A4
(en)
*
|
1989-08-28 |
1992-08-12 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
|
US5030457A
(en)
*
|
1989-08-28 |
1991-07-09 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
|
US5217712A
(en)
*
|
1989-09-20 |
1993-06-08 |
Merck & Co., Inc. |
Bioerodible thermoset elastomers
|
|
US5047464A
(en)
*
|
1989-09-20 |
1991-09-10 |
Merck & Co., Inc. |
Bioerodible thermoset elastomers
|
|
DE4002736A1
(de)
*
|
1990-01-31 |
1991-08-01 |
Hoechst Ag |
Biologisch abbaubare polymere, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe
|
|
JPH04120376U
(ja)
*
|
1991-04-16 |
1992-10-28 |
横河電機株式会社 |
リレ−検査回路
|
|
US5211951A
(en)
*
|
1991-07-24 |
1993-05-18 |
Merck & Co., Inc. |
Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
|
|
US5254345A
(en)
*
|
1991-10-11 |
1993-10-19 |
Merck & Co., Inc. |
Poly(orthocarbonate acetal) bioerodible polymers
|
|
US5461140A
(en)
*
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
|
WO1994025508A1
(en)
*
|
1993-05-03 |
1994-11-10 |
Loctite Corporation |
Polymer dispersed liquid crystals in electron-rich alkene-thiol polymers
|
|
US5401885A
(en)
*
|
1993-06-01 |
1995-03-28 |
Huls America, Inc. |
Method of preparing ortho esters and 1.1-dialkoxycycloalkanes
|
|
US5442033A
(en)
*
|
1993-07-20 |
1995-08-15 |
Ethicon, Inc. |
Liquid copolymers of epsilon-caprolactone and lactide
|
|
ES2109136B1
(es)
*
|
1994-04-22 |
1998-07-01 |
Vita Invest Sa |
Polimeros biodegradables de esqueleto carbonado de acetales de centeno y alcoholes, procedimiento para su obtencion y composicion y utilizacion correspondientes.
|
|
US5811510A
(en)
*
|
1995-04-14 |
1998-09-22 |
General Hospital Corporation |
Biodegradable polyacetal polymers and methods for their formation and use
|
|
FI98136C
(fi)
|
1995-09-27 |
1997-04-25 |
Biocon Oy |
Kudosolosuhteissa hajoava materiaali ja menetelmä sen valmistamiseksi
|
|
US5968543A
(en)
*
|
1996-01-05 |
1999-10-19 |
Advanced Polymer Systems, Inc. |
Polymers with controlled physical state and bioerodibility
|
|
US5939453A
(en)
*
|
1998-06-04 |
1999-08-17 |
Advanced Polymer Systems, Inc. |
PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
|
|
CA2336703A1
(en)
*
|
1998-07-10 |
2000-01-20 |
The University Of Sydney |
Prophylactic treatments of neovascularisation in macular degeneration
|
|
AUPQ496500A0
(en)
*
|
2000-01-06 |
2000-02-03 |
University Of Sydney, The |
Kit
|
|
US6613355B2
(en)
|
2000-05-11 |
2003-09-02 |
A.P. Pharma, Inc. |
Semi-solid delivery vehicle and pharmaceutical compositions
|
|
US20050042194A1
(en)
|
2000-05-11 |
2005-02-24 |
A.P. Pharma, Inc. |
Semi-solid delivery vehicle and pharmaceutical compositions
|
|
WO2002020663A2
(en)
|
2000-09-06 |
2002-03-14 |
Ap Pharma, Inc. |
Degradable polyacetal polymers
|
|
US6590059B2
(en)
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
|
EP1395626A1
(en)
*
|
2001-05-11 |
2004-03-10 |
AP Pharma, Inc. |
Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers
|
|
US6524606B1
(en)
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
US20040062778A1
(en)
*
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
|
US7354574B2
(en)
*
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US6863782B2
(en)
*
|
2002-11-15 |
2005-03-08 |
A.P. Pharma, Inc. |
Method of preparing di(ketene acetals)
|
|
US7045589B2
(en)
*
|
2002-11-15 |
2006-05-16 |
A.P. Pharma, Inc. |
Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
|
|
RU2005133427A
(ru)
*
|
2003-03-31 |
2006-04-27 |
Алза Корпорейшн (Us) |
Безводные однофазные носители и препараты с использованием таких носителей
|
|
US7083802B2
(en)
*
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US7056591B1
(en)
*
|
2003-07-30 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same
|
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US7083803B2
(en)
*
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
|
US7329413B1
(en)
|
2003-11-06 |
2008-02-12 |
Advanced Cardiovascular Systems, Inc. |
Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof
|
|
US9114198B2
(en)
|
2003-11-19 |
2015-08-25 |
Advanced Cardiovascular Systems, Inc. |
Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
|
|
US7220816B2
(en)
|
2003-12-16 |
2007-05-22 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same
|
|
US7435788B2
(en)
|
2003-12-19 |
2008-10-14 |
Advanced Cardiovascular Systems, Inc. |
Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
|
|
US20050192264A1
(en)
*
|
2004-02-04 |
2005-09-01 |
Penfold Philip L. |
Slow release steroid composition
|
|
US20050192257A1
(en)
*
|
2004-02-26 |
2005-09-01 |
Peyman Gholam A. |
Predictors for patients at risk for glaucoma from steroid therapy
|
|
EP1720555A1
(en)
*
|
2004-02-26 |
2006-11-15 |
Advanced Ocular Systems Limited |
Tetracycline derivatives for the treatment of ocular pathologies
|
|
US8685431B2
(en)
|
2004-03-16 |
2014-04-01 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
|
|
US8778014B1
(en)
|
2004-03-31 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for preventing balloon damage to polymer coated stents
|
|
DK1755616T3
(da)
|
2004-04-08 |
2013-11-25 |
Eye Co Pty Ltd |
Behandling af ekssudativ retinopati med mineralkortikoider
|
|
WO2005102303A2
(en)
*
|
2004-04-21 |
2005-11-03 |
Advanced Ocular Systems Limited |
Antiprostaglandins for the treatment of ocular pathologies
|
|
US20050288481A1
(en)
*
|
2004-04-30 |
2005-12-29 |
Desnoyer Jessica R |
Design of poly(ester amides) for the control of agent-release from polymeric compositions
|
|
US7820732B2
(en)
|
2004-04-30 |
2010-10-26 |
Advanced Cardiovascular Systems, Inc. |
Methods for modulating thermal and mechanical properties of coatings on implantable devices
|
|
US20050271700A1
(en)
*
|
2004-06-03 |
2005-12-08 |
Desnoyer Jessica R |
Poly(ester amide) coating composition for implantable devices
|
|
US20050287184A1
(en)
|
2004-06-29 |
2005-12-29 |
Hossainy Syed F A |
Drug-delivery stent formulations for restenosis and vulnerable plaque
|
|
US7350479B2
(en)
*
|
2004-09-10 |
2008-04-01 |
United States Of America As Represented By The Secretary Of The Army |
System and method for controlling growth of aquatic plants utilizing bio-eroding means implanted in triploid grass carp
|
|
US7166680B2
(en)
|
2004-10-06 |
2007-01-23 |
Advanced Cardiovascular Systems, Inc. |
Blends of poly(ester amide) polymers
|
|
US7390497B2
(en)
|
2004-10-29 |
2008-06-24 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) filler blends for modulation of coating properties
|
|
US8609123B2
(en)
|
2004-11-29 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Derivatized poly(ester amide) as a biobeneficial coating
|
|
US20060122152A1
(en)
*
|
2004-12-03 |
2006-06-08 |
Peyman Gholam A |
Heparin for the treatment of ocular pathologies
|
|
US7419504B2
(en)
|
2004-12-27 |
2008-09-02 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) block copolymers
|
|
US8007775B2
(en)
|
2004-12-30 |
2011-08-30 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
|
|
US7202325B2
(en)
*
|
2005-01-14 |
2007-04-10 |
Advanced Cardiovascular Systems, Inc. |
Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles
|
|
US7456213B2
(en)
*
|
2005-03-31 |
2008-11-25 |
A.P. Pharma, Inc. |
PEG-poly(ortho ester) graft copolymers and pharmaceutical compositions
|
|
EP1865988A2
(en)
*
|
2005-03-31 |
2007-12-19 |
AP Pharma, Inc. |
Peg-polyacetal diblock and triblock copolymers and pharmaceutical compositions
|
|
WO2007011880A2
(en)
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
|
US20070020312A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Desnoyer Jessica R |
Method of fabricating a bioactive agent-releasing implantable medical device
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8377462B2
(en)
*
|
2005-07-29 |
2013-02-19 |
Advanced Cardiovascular Systems, Inc. |
PEA-TEMPO/PEA-BZ coatings for controlled delivery of drug from implantable medical devices
|
|
US7713916B2
(en)
|
2005-09-22 |
2010-05-11 |
Halliburton Energy Services, Inc. |
Orthoester-based surfactants and associated methods
|
|
US20070066493A1
(en)
*
|
2005-09-22 |
2007-03-22 |
Halliburton Energy Services, Inc. |
Orthoester-based surfactants and associated methods
|
|
US7919637B2
(en)
*
|
2005-10-11 |
2011-04-05 |
Fujifilm Corporation |
Fluorine-containing spiroacetal compound and method of producing the same
|
|
EP1948271B1
(en)
|
2005-11-17 |
2013-10-02 |
Zogenix, Inc. |
Delivery of viscous formulations by needle-free injection
|
|
US7910152B2
(en)
*
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
|
DK2374472T3
(en)
|
2006-03-16 |
2018-08-13 |
Dyax Corp |
Compositions and Methods for the Treatment of Eye Disorders
|
|
US20070265329A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Devang Shah T |
Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
|
|
US20070264338A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Shah Devang T |
Base-stabilized polyorthoester formulations
|
|
US20070264339A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Ap Pharma, Inc. |
Base-stabilized polyorthoester formulations
|
|
US7306040B1
(en)
*
|
2006-06-02 |
2007-12-11 |
Halliburton Energy Services, Inc. |
Stimuli-degradable gels
|
|
US20070281870A1
(en)
*
|
2006-06-02 |
2007-12-06 |
Halliburton Energy Services, Inc. |
Stimuli-degradable gels
|
|
US20090258028A1
(en)
*
|
2006-06-05 |
2009-10-15 |
Abbott Cardiovascular Systems Inc. |
Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
|
|
US8323676B2
(en)
*
|
2008-06-30 |
2012-12-04 |
Abbott Cardiovascular Systems Inc. |
Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
|
|
US7458953B2
(en)
*
|
2006-06-20 |
2008-12-02 |
Gholam A. Peyman |
Ocular drainage device
|
|
US7875697B2
(en)
*
|
2006-06-29 |
2011-01-25 |
Medtronic, Inc. |
Poly(orthoester) polymers, and methods of making and using same
|
|
US7771739B2
(en)
*
|
2006-06-30 |
2010-08-10 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices comprising semi-crystalline poly(ester-amide)
|
|
US9028859B2
(en)
|
2006-07-07 |
2015-05-12 |
Advanced Cardiovascular Systems, Inc. |
Phase-separated block copolymer coatings for implantable medical devices
|
|
ES2603399T3
(es)
|
2006-07-10 |
2017-02-27 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Anticuerpos scFv que atraviesan capas epiteliales y/o endoteliales
|
|
US20090181063A1
(en)
*
|
2006-07-13 |
2009-07-16 |
Michael Huy Ngo |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
|
US8030436B2
(en)
*
|
2006-07-13 |
2011-10-04 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester-amide) elastomers and their use with implantable medical devices
|
|
US7731987B2
(en)
*
|
2006-07-13 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
|
US20080014245A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Stephen Pacetti |
Drug-eluting implantable medical device with free radical scavenger for protecting drugs during sterilization and related method
|
|
US8268347B1
(en)
|
2006-10-24 |
2012-09-18 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
|
US20080114076A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Alcon Manufacturing Ltd. |
Punctal plug comprising a water-insoluble polymeric matrix
|
|
JP5411703B2
(ja)
*
|
2006-11-09 |
2014-02-12 |
アルコン リサーチ， リミテッド |
薬物送達のための水不溶性ポリマーマトリクス
|
|
US20080175882A1
(en)
*
|
2007-01-23 |
2008-07-24 |
Trollsas Mikael O |
Polymers of aliphatic thioester
|
|
US8252361B2
(en)
*
|
2007-06-05 |
2012-08-28 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices for local and regional treatment
|
|
US20080306584A1
(en)
*
|
2007-06-05 |
2008-12-11 |
Pamela Kramer-Brown |
Implantable medical devices for local and regional treatment
|
|
US9737638B2
(en)
*
|
2007-06-20 |
2017-08-22 |
Abbott Cardiovascular Systems, Inc. |
Polyester amide copolymers having free carboxylic acid pendant groups
|
|
US7927621B2
(en)
*
|
2007-06-25 |
2011-04-19 |
Abbott Cardiovascular Systems Inc. |
Thioester-ester-amide copolymers
|
|
US8956642B2
(en)
|
2008-04-18 |
2015-02-17 |
Medtronic, Inc. |
Bupivacaine formulation in a polyorthoester carrier
|
|
US8475823B2
(en)
|
2008-04-18 |
2013-07-02 |
Medtronic, Inc. |
Baclofen formulation in a polyorthoester carrier
|
|
US20110118189A1
(en)
|
2008-04-28 |
2011-05-19 |
Farr Stephen J |
Novel formulations for treatment of migraine
|
|
US8889172B1
(en)
|
2008-04-30 |
2014-11-18 |
Abbott Cardiovascular Systems Inc. |
Amorphous or semi-crystalline poly(ester amide) polymer with a high glass transition temperature
|
|
EP2303393A4
(en)
*
|
2008-05-07 |
2011-10-19 |
Obj Ltd |
METHOD AND APPARATUS FOR ENHANCED TRANSDERMAL DIFFUSION
|
|
US8765162B2
(en)
*
|
2008-06-30 |
2014-07-01 |
Abbott Cardiovascular Systems Inc. |
Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
|
|
JP2011528379A
(ja)
|
2008-07-17 |
2011-11-17 |
メリアル リミテッド |
ポリオルトエステルの安定性を増強する方法及びそれらの処方物
|
|
US20100047319A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Michael Huy Ngo |
Biodegradable Poly(Ester-Amide) And Poly(Amide) Coatings For Implantable Medical Devices With Enhanced Bioabsorption Times
|
|
JP2012512163A
(ja)
*
|
2008-12-11 |
2012-05-31 |
エーピー ファーマ， インコーポレイテッド |
ポリオルトエステルおよびそれらの製剤の安定性を高めるための方法
|
|
EP2488640B1
(en)
|
2009-10-14 |
2018-09-26 |
Nanyang Technological University |
Antiproliferative agent
|
|
EP2343046A1
(en)
|
2010-01-08 |
2011-07-13 |
Nirvana's Tree House B.V. |
Functionalised triblock copolymers and compositions containing such polymers
|
|
WO2011146978A1
(en)
|
2010-05-25 |
2011-12-01 |
International Scientific Pty Ltd |
Delivery of oral care products
|
|
EP2582424A4
(en)
|
2010-06-17 |
2014-08-06 |
Internat Scient Pty Ltd |
DISTRIBUTION OF SKIN CARE PRODUCTS
|
|
AU2012220564A1
(en)
|
2011-02-23 |
2013-08-29 |
Ams Research Corporation |
Drug releasing pelvic treatment system and method
|
|
EP2677960A4
(en)
|
2011-02-23 |
2016-11-16 |
Boston Scient Scimed Inc |
Basin IMPLANT AND THERAPY PROCESSING SYSTEM AND METHOD
|
|
AU2012340107B2
(en)
|
2011-11-18 |
2017-06-15 |
Regeneron Pharmaceuticals, Inc. |
Polymer protein microparticles
|
|
US10220093B2
(en)
|
2013-02-28 |
2019-03-05 |
Mira Pharma Corporation |
Long-acting semi-solid lipid formulations
|
|
US9849180B2
(en)
|
2014-09-15 |
2017-12-26 |
Hui Rong Shen |
Long-acting semi-solid lipid formulations
|
|
US9592227B2
(en)
|
2013-03-15 |
2017-03-14 |
Heron Therapeutics, Inc. |
Compositions of a polyorthoester and an aprotic solvent
|
|
CN106535886A
(zh)
|
2014-04-21 |
2017-03-22 |
赫伦治疗有限公司 |
长效聚合物输送系统
|
|
EP3509601A1
(en)
|
2014-04-21 |
2019-07-17 |
Heron Therapeutics, Inc. |
A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
|
|
JP6723162B2
(ja)
|
2014-04-21 |
2020-07-15 |
ヘロン セラピューティクス， インコーポレイテッドＨｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
ポリオルトエステルおよび有機酸添加剤の組成物
|
|
US9801945B2
(en)
|
2014-04-21 |
2017-10-31 |
Heron Therapeutics, Inc. |
Long-acting polymeric delivery systems
|
|
EP3154552B1
(en)
|
2014-06-11 |
2021-03-24 |
International Scientific Pty Ltd |
Device and method to treat or prevent joint degeneration
|
|
AU2016342374B2
(en)
|
2015-10-23 |
2022-08-04 |
Nortiva Bio, Inc. |
Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
|
|
KR102796240B1
(ko)
|
2015-12-08 |
2025-04-16 |
린드라 테라퓨틱스 인코퍼레이티드 |
위 체류 시스템을 위한 기하 구성형태
|
|
MY200764A
(en)
|
2015-12-16 |
2024-01-14 |
Regeneron Pharma |
Compositions and methods of manufacturing protein microparticles
|
|
US12109305B2
(en)
|
2016-05-27 |
2024-10-08 |
Lyndra Therapeutics, Inc. |
Materials architecture for gastric residence systems
|
|
EP3518902A4
(en)
|
2016-09-30 |
2020-07-08 |
Lyndra, Inc. |
GASTRIC RESIDENCE SYSTEMS FOR LONG-TERM ADMINISTRATION OF ADAMANTANE CLASS MEDICINES
|
|
CA3059449A1
(en)
|
2017-04-24 |
2018-11-01 |
Cocrystal Pharma, Inc. |
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
|
|
TWI811221B
(zh)
|
2017-06-09 |
2023-08-11 |
美商萊恩卓治療公司 |
具有釋放速率調節膜之胃的滯留系統
|
|
WO2018232323A1
(en)
|
2017-06-16 |
2018-12-20 |
Avery Therapeutics, Inc. |
Three dimensional tissue compositions and methods of use
|
|
JP7288435B2
(ja)
|
2017-09-20 |
2023-06-07 |
リンドラ セラピューティクス， インコーポレイティド |
胃内滞留システムのカプセル封入
|
|
US10561606B2
(en)
|
2017-12-06 |
2020-02-18 |
Mira Pharma Corporation |
Injectable long-acting local anesthetic semi-solid gel formulations
|
|
US11426418B2
(en)
|
2017-12-06 |
2022-08-30 |
Mira Pharma Corporation |
Injectable long-acting semi-solid gel formulations
|
|
TWI821343B
(zh)
|
2018-07-27 |
2023-11-11 |
美商共結晶製藥公司 |
流感病毒複製之抑制劑
|
|
EP3849978B1
(en)
|
2018-09-10 |
2022-11-02 |
Cocrystal Pharma, Inc. |
Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication
|
|
WO2020081751A1
(en)
|
2018-10-17 |
2020-04-23 |
Cocrystal Pharma, Inc. |
Combinations of inhibitors of influenza virus replication
|
|
EP3887355A1
(en)
|
2018-11-26 |
2021-10-06 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
|
US11730793B2
(en)
|
2019-11-25 |
2023-08-22 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous emulsions
|
|
WO2021146215A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
|
US20230151034A1
(en)
|
2020-03-17 |
2023-05-18 |
Cocrystal Pharma, Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
|
IL297069A
(en)
|
2020-04-10 |
2022-12-01 |
Cocrystal Pharma Inc |
Replication inhibitors of norovirus and corona virus
|
|
WO2021206877A1
(en)
|
2020-04-10 |
2021-10-14 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
|
US12558415B2
(en)
|
2020-04-14 |
2026-02-24 |
The Regents Of The University Of California |
Broad-spectrum multi-antigen pan-coronavirus vaccine
|
|
EP4135762A4
(en)
|
2020-04-14 |
2024-05-15 |
The Regents of the University of California |
Large sequence pan-coronavirus vaccine compositions
|
|
EP4251128A1
(en)
|
2020-11-25 |
2023-10-04 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous membrane emulsification
|
|
CA3203561A1
(en)
|
2021-01-12 |
2022-07-21 |
Adrian Neil Verity |
Sustained release drug delivery systems and related methods
|
|
JP2024530920A
(ja)
|
2021-08-03 |
2024-08-27 |
コクリスタル ファーマ，インコーポレイテッド |
コロナウイルスに対する阻害剤
|
|
AR132416A1
(es)
|
2023-04-12 |
2025-06-25 |
Centennial Therapeutics Llc |
Compuestos de pirimidina disustituidos para la inhibición de la cetohexoquinasa
|
|
KR20260022334A
(ko)
|
2023-05-31 |
2026-02-19 |
센테니얼 테라퓨틱스, 엘엘씨 |
케토헥소키나제 억제를 위한 이환식 화합물
|
|
WO2025175208A1
(en)
|
2024-02-16 |
2025-08-21 |
The Regents Of The University Of California |
Intra-vascular drug delivery device and method for focal drug delivery by vascular perfusion
|
|
WO2026080597A1
(en)
|
2024-10-08 |
2026-04-16 |
Regeneron Pharmaceuticals, Inc. |
Sustained delivery of biologics and non-aqueous manufacture of same
|